| scholarly article | Q13442814 |
| P2093 | author name string | Janine Büchel | |
| Kristina Gundlach | |||
| André Fragoso | |||
| Pedro Leão Neves | |||
| Ana Paula Silva | |||
| P2860 | cites work | Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis | Q43768128 |
| Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients | Q46567248 | ||
| The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients | Q49077132 | ||
| Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. | Q51496620 | ||
| Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease. | Q53149178 | ||
| Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. | Q53371967 | ||
| Does hypomagnesemia have an adaptive role in hypertension? | Q53902844 | ||
| The Interaction of Vascular Stiffness and Cardiovascular Events in Women | Q57652922 | ||
| Pulse pressure monitoring of open antihypertensive therapy | Q81164769 | ||
| Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients | Q81518835 | ||
| Magnesium and arterial stiffness | Q82362436 | ||
| The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe? | Q82745814 | ||
| Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients | Q84976574 | ||
| Hypomagnesaemia, the kidney and the vessels | Q26853709 | ||
| Magnesium stimulates renal phosphate reabsorption | Q28576857 | ||
| Hypomagnesemia | Q33686748 | ||
| Blood pressure and vascular calcification | Q33742676 | ||
| Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum | Q33808444 | ||
| Serum magnesium, ambulatory blood pressure, and carotid artery alteration: the Ohasama study. | Q34131046 | ||
| Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease | Q34193189 | ||
| Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification | Q34241357 | ||
| Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease | Q34479134 | ||
| Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. | Q34749645 | ||
| FGF-23: More than a regulator of renal phosphate handling? | Q35156017 | ||
| FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis | Q35272291 | ||
| Magnesium and vascular changes in hypertension | Q35821244 | ||
| Pathophysiology of vascular calcification in chronic kidney disease | Q35890848 | ||
| Role of magnesium in hypertension | Q36500637 | ||
| Hypomagnesemia in patients with type 2 diabetes | Q36910562 | ||
| Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration | Q37542842 | ||
| Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications | Q37832285 | ||
| The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases | Q37872124 | ||
| Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk | Q38009044 | ||
| Vascular calcification and cardiovascular function in chronic kidney disease | Q39735035 | ||
| FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment | Q39866881 | ||
| Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival | Q42718947 | ||
| P433 | issue | 2 | |
| P921 | main subject | renal dialysis | Q202301 |
| chronic renal insufficiency | Q736715 | ||
| P304 | page(s) | 161-166 | |
| P577 | publication date | 2014-02-13 | |
| P1433 | published in | Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) | Q26842221 |
| P1476 | title | Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients | |
| P478 | volume | 7 |
| Q89441468 | Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis |
| Q88770632 | Interpreting magnesium status to enhance clinical care: key indicators |
| Q35671325 | Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients |
| Q54963847 | Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials. |
| Q38473932 | Magnesium and cardiovascular complications of chronic kidney disease |
| Q27027086 | Magnesium in CKD: more than a calcification inhibitor? |
| Q35227651 | Magnesium: a renewed player of vascular ageing in diabetic CKD patients? |
| Q36716833 | The Biology of Hemodialysis Vascular Access Failure |
| Q26775058 | The molecular mechanisms of hemodialysis vascular access failure |
Search more.